Business

RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC

RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC.

articleReplicel Life Sciences Inc.June 5, 20154/company/replicel-life-sciences-inc/news/replicel-life-sciences-announces-participation-in-23rd-world-congress-of-dermatology-vancouver-bc
RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC

About this update from Replicel Life Sciences Inc.

[{"type":"text","content":"\n\n\n\nRepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nRepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC\nPR Newswire\nVANCOUVER, June 5, 2015\n\n\n\nConference program to include presentations on the clinical development of RepliCel's skin rejuvenation, hair regeneration, and tendon repair technologies\n\n\n\nVANCOUVER, June 5, 2015 /CNW/ - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that RepliCel's technology founders and management will be attending the 23rd World Congress of Dermatology (\"WCD\") 2015 held in Vancouver, British Columbia, Canada. This year's congress will take place from June 8 – 13, 2015 at the Vancouver Trade and Convention Centre. The RepliCel team will be involved in multiple sessions spanning the length of this conference.  Chief Scientific Officer, Dr. Kevin McElwee will be chairing a session entitled: \"Hair Biology and its exploitation in health and disease\" on Tuesday, June 9th from 8 – 10 AM PST in West 2015-107.  Dr. McElwee will also be giving a poster presentation entitled: \"Hair-follicle derived mesenchymal cells in cell therapy: multiple therapeutic applications\" on Thursday, June 11th from 9 AM – 1PM PST. Chief Medical Officer, Dr. Rolf Hoffmann, will be coming from Germany to co-chair a session entitled: \"Alopecia Areata\" on Thursday June 11th from 2:30 – 4:30 PM PST in West 223-224.  Also present at this conference will be RepliCel's CEO David Hall, VP Business and Corporate Development Lee Buckler, and Director of Research and Development Dr. Hisae Nakamura. \n\n\"We are pleased Vancouver is host to this year's World Congress of Dermatology and excited to be participating among the world's leading experts advancing science and technology in dermatology.  We congratulate...

More updates from Replicel Life Sciences Inc.